Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
department is highly interdisciplinary with informatics researchers working closely together with practicing cardiologists to advance the use of AI for personalised treatment. The ultimate goal is to be able
-
sensitive to disruption of the RNA splicing machinery. The project combines molecular biology, cell biology and genomics with state-of-the-art technologies such as confocal microscopy and (single-cell) RNA
-
remodels and heals under controlled in vitro conditions. In the first phase, you will validate and implement the BBoC technology. In the translational phase, you will study how a candidate pharmaceutical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
The cerebral vascular bed does more than supply blood to the brain. It also maintains the blood-brain barrier and helps remove waste products through the so-called glymphatic system. The glymphatic system consists of channels surrounding the blood vessels. Through these channels, substances move...
-
Vrije Universiteit Brussel (VUB) is the recruiting organisation for this position. You will be employed by the Molecular Imaging and Therapy (MITH) research group and embedded in the POLARIS consortium. Your academic supervision will be provided by Prof. Timo De Groof and Prof. Nick...
-
The Neuropathology Research team is part of the department of Pathology at Amsterdam UMC. The team consists of neuroscientists and neuropathologists working on research into neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia and ALS, as well as other brain...
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical